FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2191453721> ?p ?o ?g. }

• W2191453721 endingPage "377" @default.
• W2191453721 startingPage "368" @default.
• W2191453721 abstract "Chronic lymphocytic leukemia (CLL) is usually diagnosed in early stage, asymptomatic patients, and, although a wealth of prognostic parameters have been identified, the standard approach is a watch and wait strategy irrespective of risk factors. Therapy is only indicated if active disease criteria (International Workshop on Chronic Lymphocytic Leukemia guidelines) are met, and the routine upfront treatment is a combination of CD20 antibody (rituximab, ofatumumab or obinutuzumab) and chemotherapy (fludarabine /cyclophosphamide, bendamustine, chlorambucil), with the choice mainly determined by physical fitness of the patient. The major subgroup in which this approach does not result into satisfactory efficacy is in CLL with 17p deletion (17p-) or TP53 mutation (TP53mut). Likewise, patients with a short initial response duration (i.e., <24-26 months) have a dismal outcome with chemoimmunotherapy salvage. Therefore, these patients have been referred to as ultra high risk, and, in these subgroups, novel agents such as signaling kinase inhibitors (also termed B-cell receptor signaling inhibitors; e.g., ibrutinib targeting Bruton tryosine kinase, idelalisib targeting phosphoinositide 3-kinase) and BCL2 antagonists (venetoclax, formerly ABT-199/GDC-0199) have shown dramatic efficacy. Ibrutinib and idelalisib are currently approved for the treatment of relapsed or refractory CLL or frontline treatment of 17p-/TP53mut CLL regardless of fitness. Therefore, these agents are challenging the concept of adjusting treatment to fitness and TP53 status, because they offer remarkable efficacy combined with exceptional tolerability. Nevertheless, it appears that 17p-/TP53mut retains an adverse prognostic impact, making additional improvement a primary research goal aimed at the development of the best combinations and/or sequences of these new agents, as well as prognostic and predictive markers guiding their use." @default.
• W2191453721 created "2016-06-24" @default.
• W2191453721 creator A5019866348 @default.
• W2191453721 date "2015-12-05" @default.
• W2191453721 modified "2023-10-02" @default.
• W2191453721 title "Prognostic markers and standard management of chronic lymphocytic leukemia" @default.
• W2191453721 cites W1026324699 @default.
• W2191453721 cites W1583020806 @default.
• W2191453721 cites W171737206 @default.
• W2191453721 cites W1965851569 @default.
• W2191453721 cites W1966267239 @default.
• W2191453721 cites W1970312642 @default.
• W2191453721 cites W1977528398 @default.
• W2191453721 cites W1979960325 @default.
• W2191453721 cites W1986924929 @default.
• W2191453721 cites W1987282310 @default.
• W2191453721 cites W1987819921 @default.
• W2191453721 cites W1994709165 @default.
• W2191453721 cites W1999128869 @default.
• W2191453721 cites W2001343785 @default.
• W2191453721 cites W2001850157 @default.
• W2191453721 cites W2004739040 @default.
• W2191453721 cites W2010779916 @default.
• W2191453721 cites W2016042196 @default.
• W2191453721 cites W2023976667 @default.
• W2191453721 cites W2025391536 @default.
• W2191453721 cites W2037648016 @default.
• W2191453721 cites W2038678963 @default.
• W2191453721 cites W2040040334 @default.
• W2191453721 cites W2041925366 @default.
• W2191453721 cites W2055611408 @default.
• W2191453721 cites W2058786179 @default.
• W2191453721 cites W2063204645 @default.
• W2191453721 cites W2066564017 @default.
• W2191453721 cites W2067064694 @default.
• W2191453721 cites W2071549499 @default.
• W2191453721 cites W2084952484 @default.
• W2191453721 cites W2088580309 @default.
• W2191453721 cites W2091416193 @default.
• W2191453721 cites W2091664866 @default.
• W2191453721 cites W2095447519 @default.
• W2191453721 cites W2096669347 @default.
• W2191453721 cites W2097852595 @default.
• W2191453721 cites W2100456851 @default.
• W2191453721 cites W2104168678 @default.
• W2191453721 cites W2108206643 @default.
• W2191453721 cites W2111403010 @default.
• W2191453721 cites W2113278680 @default.
• W2191453721 cites W2116324811 @default.
• W2191453721 cites W2116835043 @default.
• W2191453721 cites W2120319857 @default.
• W2191453721 cites W2128213592 @default.
• W2191453721 cites W2134253126 @default.
• W2191453721 cites W2137858990 @default.
• W2191453721 cites W2140395974 @default.
• W2191453721 cites W2140606816 @default.
• W2191453721 cites W2140791665 @default.
• W2191453721 cites W2142099365 @default.
• W2191453721 cites W2143749371 @default.
• W2191453721 cites W2144617723 @default.
• W2191453721 cites W2149868826 @default.
• W2191453721 cites W2150487985 @default.
• W2191453721 cites W2157799317 @default.
• W2191453721 cites W2159982252 @default.
• W2191453721 cites W2160902234 @default.
• W2191453721 cites W2169269721 @default.
• W2191453721 cites W2171443164 @default.
• W2191453721 cites W2172242534 @default.
• W2191453721 cites W2246620886 @default.
• W2191453721 cites W2317888977 @default.
• W2191453721 cites W2318933236 @default.
• W2191453721 cites W2323897083 @default.
• W2191453721 cites W2444166753 @default.
• W2191453721 cites W2473105612 @default.
• W2191453721 cites W2515468273 @default.
• W2191453721 cites W4233553545 @default.
• W2191453721 cites W4376595664 @default.
• W2191453721 cites W62561355 @default.
• W2191453721 cites W981207258 @default.
• W2191453721 doi "https://doi.org/10.1182/asheducation-2015.1.368" @default.
• W2191453721 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26637745" @default.
• W2191453721 hasPublicationYear "2015" @default.
• W2191453721 type Work @default.
• W2191453721 sameAs 2191453721 @default.
• W2191453721 citedByCount "29" @default.
• W2191453721 countsByYear W21914537212016 @default.
• W2191453721 countsByYear W21914537212017 @default.
• W2191453721 countsByYear W21914537212018 @default.
• W2191453721 countsByYear W21914537212019 @default.
• W2191453721 countsByYear W21914537212020 @default.
• W2191453721 countsByYear W21914537212021 @default.
• W2191453721 countsByYear W21914537212023 @default.
• W2191453721 crossrefType "journal-article" @default.
• W2191453721 hasAuthorship W2191453721A5019866348 @default.
• W2191453721 hasBestOaLocation W21914537211 @default.
• W2191453721 hasConcept C126322002 @default.
• W2191453721 hasConcept C143998085 @default.
• W2191453721 hasConcept C2776694085 @default.

• next